Searchable abstracts of presentations at key conferences in endocrinology

ea0050p206 | Diabetes and Cardiovascular | SFEBES2017

The impact of a dedicated metabolic hepatology clinic for the treatment of non-alcoholic fatty liver disease

Motohashi Kenzo , Moolla Ahmad , Marjot Tom , Ainsworth Mark , Tomlinson Jeremy , Cobbold Jeremy

Introduction: Non-Alcoholic Fatty Liver Disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is tightly associated with insulin resistance and type 2 diabetes (T2DM), both risk factors for disease progression, liver failure and cardiovascular complications. A multidisciplinary approach involving hepatologists and diabetologists working alongside allied health professionals is thus advocated for the management of NAFLD. Interv...

ea0050oc1.2 | Early Career Oral Communications | SFEBES2017

Co-administration of 5α-reductase inhibitors worsens the adverse metabolic effects of prescribed glucocorticoids

Marjot Tom , Othonos Nantia , Woods Conor , Hazlehurst Jonathan , Moolla Ahmad , Hodson Leanne , Tomlinson Jeremy

Glucocorticoids (GC) are commonly prescribed and their use is associated with adverse metabolic side effects. 5a-reductase (5aR) inhibitors are also frequently prescribed mainly for their ability to inhibit the conversion of testosterone to dihydrotestosterone. However, they also have a role to inactivate and clear GCs. We hypothesised that 5aR inhibitors have the potential to exacerbate the adverse metabolic effects of GCs. We conducted a prospective, randomised, study in 19 ...

ea0050p206 | Diabetes and Cardiovascular | SFEBES2017

The impact of a dedicated metabolic hepatology clinic for the treatment of non-alcoholic fatty liver disease

Motohashi Kenzo , Moolla Ahmad , Marjot Tom , Ainsworth Mark , Tomlinson Jeremy , Cobbold Jeremy

Introduction: Non-Alcoholic Fatty Liver Disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is tightly associated with insulin resistance and type 2 diabetes (T2DM), both risk factors for disease progression, liver failure and cardiovascular complications. A multidisciplinary approach involving hepatologists and diabetologists working alongside allied health professionals is thus advocated for the management of NAFLD. Interv...

ea0086p292 | Thyroid | SFEBES2022

Thyroid Storm presenting without fever

Iqbal Khan Irfan , Tahir Chohan Muhammad , Ahmad Waqar , Ali Zainab , De Los Angeles Maillo-Nieto Maria

Thyroid storm is rare and life threatening manifestation of thyroid hormone excess. It has high mortality rate with delayed treatment. As early intervention is associated with improved patient outcome, prompt diagnosis based on clinical grounds is of paramount importance. We present a case of thyroid storm which was different in terms of absence of fever on presentation, presence of thrombocytopenia and deranged cholestatic LFTs which resolved after treatment of thyroid storm....

ea0090ep436 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Audit on the effect of oral Semaglutide on HbA1c and Weight reduction in type 2 diabetes

Ahmad Waqar , Maliekal Alex , Malik Leena , Telalagic Denisa , Peter Paul , Partha Praveen

Background: Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) which is widely used for the management of type 2 diabetes as well as for the obesity treatment. Evidence suggest that the level of HbA1c reduction and weight loss with oral semaglutide were similar to those of the subcutaneous formulation1. However, oral formulation not only improves the patient’s compliance to treatment but also makes it a favourable option for those who are relu...

ea0090ep831 | Pituitary and Neuroendocrinology | ECE2023

Pituitary Abscess – A challenge to diagnose preoperatively

Ahmad Waqar , Nichols Matthew , Johnson Karen , Nicholson Claire , Mamoojee Yaasir , Joshi Ashwin

Background: Pituitary abscess is rare but a serious intrasellar infection. It should be considered in the differential diagnosis of the sellar masses due to its high morbidity and mortality rates. Despite recent advances in radiological investigations, it remains a challenge to make a definitive diagnosis preoperatively [1]. We present a case of pituitary abscess who presented with pan hypopituitarism and central diabetes insipidus.Case presen...

ea0065p56 | Adrenal and Cardiovascular | SFEBES2019

A case of anaphylaxis in phaeochromocytoma

Mohamed Issam , Morrison Amy , Ahmad Farooq , Brewer Alison , Ugur Antonia , Hughes David

Introduction: The physiological actions of catecholamines have led to the empirical use of adrenaline in the management of anaphylaxis, with alpha-adrenergic activation increasing peripheral vascular resistance and beta-adrenergic activation relaxing bronchial smooth muscle and inhibiting histamine release. Supraphysiological levels of catecholamines are released by phaeochromocytoma and hence blockade of these same receptors is required for symptom control, prevention of end ...

ea0049gp70 | Developmental & Protein Endocrinology | ECE2017

The adverse effects of prescribed glucocorticoids are worsened by co-administration of 5α-reductase inhibitors

Marjot Tom , Othonos Nantia , Woods Conor , Hazlehurst Jonathan , Moola Ahmad , Hodson Leanne , Tomlinson Jeremy

Introduction: Glucocorticoids (GC) are prescribed to 2–3% of the population of the UK and USA. Their use is associated with a significant side effect profile that includes the development of central obesity, insulin resistance and type 2 diabetes. 5α-reductase (5αR) inhibitors (Finasteride and Dutasteride) are also commonly prescribed in the context of prostate disease, where they inhibit the conversion of testosterone to dihydrotestosterone. Additionally, they ...